Energy crisis precedes global metabolic failure in a novel Caenorhabditis elegans Alzheimer Disease model

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Fong, Sheng ^a   Teo, Emelyne ^b   Ng, Li Fang ^c   Chen, Ce Belle ^d   Lakshmanan, Lakshmi Narayanan ^e   Tsoi, Sau Yee ^c   Moore, Philip Keith ^b   Inoue, Takao ^d   Halliwell, Barry ^d   Gruber, Jan ^c,d  

^a Singapore Health Services   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c YALE NUS COLLEGE   (Singapore)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^e ETH ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84988632507     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep33781     Document Type: Article

References (37)

1. Glenner, G. G., Wong, C. W. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120, 885-890 (1984).
2. Grundke-Iqbal, I. et al. Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. J Biol Chem 261, 6084-6089 (1986).
3. Muller, W. E., Eckert, A., Kurz, C., Eckert, G. P., Leuner, K. Mitochondrial dysfunction: common final pathway in brain aging and Alzheimer's disease-therapeutic aspects. Mol Neurobiol 41, 159-171, doi: 10. 1007/s12035-010-8141-5 (2010).
4. Schmitt, K. et al. Insights into mitochondrial dysfunction: aging, amyloid-beta, and tau-A deleterious trio. Antioxid Redox Signal 16, 1456-1466, doi: 10. 1089/ars. 2011. 4400 (2012).
5. Ng, L. F. et al. The mitochondria-targeted antioxidant MitoQ extends lifespan and improves healthspan of a transgenic Caenorhabditis elegans model of Alzheimer disease. Free Radic Biol Med 71, 390-401, doi: 10. 1016/j. freeradbiomed. 2014. 03. 003 (2014).
6. Gruber, J. et al. Caenorhabditis elegans: What We Can and Cannot Learn from Aging Worms. Antioxid Redox Signal 23, 256-279, doi: 10. 1089/ars. 2014. 6210 (2015).
7. McColl, G. et al. The Caenorhabditis elegans A beta 1-42 model of Alzheimer disease predominantly expresses A beta 3-42. J Biol Chem 284, 22697-22702, doi: 10. 1074/jbc. C109. 028514 (2009).
8. McColl, G. et al. Utility of an improved model of amyloid-beta (A? (1-42)) toxicity in Caenorhabditis elegans for drug screening for Alzheimer's disease. Mol Neurodegener 7, 57 (2012).
9. Herndon, L. A. et al. Stochastic and genetic factors influence tissue-specific decline in ageing C. elegans. Nature 419, 808-814, doi: 10. 1038/nature01135 (2002).
10. Trent, C., Tsuing, N., Horvitz, H. R. Egg-laying defective mutants of the nematode Caenorhabditis elegans. Genetics 104, 619-647 (1983).
11. Pickett, C. L., Kornfeld, K. Age-related degeneration of the egg-laying system promotes matricidal hatching in Caenorhabditis elegans. Aging Cell 12, 544-553, doi: 10. 1111/acel. 12079 (2013).
12. Liu, D. W., Thomas, J. H. Regulation of a periodic motor program in C. elegans. J Neurosci 14, 1953-1962 (1994).
13. Avery, L., You, Y. J. C. elegans feeding. WormBook 1-23, doi: 10. 1895/wormbook. 1. 150. 1 (2012).
14. Stiernagle, T. Maintenance of C. elegans. Wormbook: the online review of C. elegans biology, 1-11 (2006).
15. Nyamsuren, O., Faggionato, D., Loch, W., Schulze, E., Baumeister, R. A mutation in CHN-1/CHIP suppresses muscle degeneration in Caenorhabditis elegans. Dev Biol 312, 193-202, doi: 10. 1016/j. ydbio. 2007. 09. 033 (2007).
16. Fong, S. et al. Identification of previously cryptic metabolic defects in the Complex II Caenorhabditis elegans mev-1 mutant strain using metabolic flux analysis. Biogerontology (under review) (2015).
17. Terada, H. Uncouplers of oxidative phosphorylation. Environ Health Perspect 87, 213-218 (1990).
18. Hauptmann, S. et al. Mitochondrial dysfunction: an early event in Alzheimer pathology accumulates with age in AD transgenic mice. Neurobiol Aging 30, 1574-1586, doi: 10. 1016/j. neurobiolaging. 2007. 12. 005 (2009).
19. Harris, J. J., Jolivet, R., Attwell, D. Synaptic energy use and supply. Neuron 75, 762-777, doi: 10. 1016/j. neuron. 2012. 08. 019 (2012).
20. Link, C. D. Expression of human beta-amyloid peptide in transgenic Caenorhabditis elegans. Proc Natl Acad Sci USA 92, 9368-9372 (1995).
21. Chen, Z., Zhong, C. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies. Prog Neurobiol 108, 21-43, doi: 10. 1016/j. pneurobio. 2013. 06. 004 (2013).
22. Allaman, I. et al. Amyloid-beta aggregates cause alterations of astrocytic metabolic phenotype: impact on neuronal viability. J Neurosci 30, 3326-3338, doi: 10. 1523/jneurosci. 5098-09. 2010 (2010).
23. Tarczyluk, M. A. et al. Amyloid beta 1-42 induces hypometabolism in human stem cell-derived neuron and astrocyte networks. J Cereb Blood Flow Metab 35, 1348-1357, doi: 10. 1038/jcbfm. 2015. 58 (2015).
24. Boyd-Kimball, D. et al. Proteomic identification of proteins specifically oxidized in Caenorhabditis elegans expressing human Abeta(1-42): implications for Alzheimer's disease. Neurobiol Aging 27, 1239-1249, doi: 10. 1016/j. neurobiolaging. 2005. 07. 001 (2006).
25. Nicholson, R. M. et al. Regional cerebral glucose uptake in the 3xTG model of Alzheimer's disease highlights common regional vulnerability across AD mouse models. Brain Res 1347, 179-185, doi: 10. 1016/j. brainres. 2010. 05. 084 (2010).
26. Nicolakakis, N. et al. Complete rescue of cerebrovascular function in aged Alzheimer's disease transgenic mice by antioxidants and pioglitazone, a peroxisome proliferator-activated receptor gamma agonist. J Neurosci 28, 9287-9296, doi: 10. 1523/jneurosci. 3348-08. 2008 (2008).
27. Hoyer, S. Causes and consequences of disturbances of cerebral glucose metabolism in sporadic Alzheimer disease: therapeutic implications. Adv Exp Med Biol 541, 135-152 (2004).
28. Grothe, M. J., Heinsen, H., Amaro, E. Jr., Grinberg, L. T., Teipel, S. J. Cognitive Correlates of Basal Forebrain Atrophy and Associated Cortical Hypometabolism in Mild Cognitive Impairment. Cereb Cortex, doi: 10. 1093/cercor/bhv062 (2015).
29. Mosconi, L., Pupi, A., De Leon, M. J. Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer's disease. Ann N Y Acad Sci 1147, 180-195, doi: 10. 1196/annals. 1427. 007 (2008).
30. McManus, M. J., Murphy, M. P., Franklin, J. L. The mitochondria-targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer's disease. J Neurosci 31, 15703-15715, doi: 10. 1523/JNEUROSCI. 0552-11. 2011 (2011).
31. Bello, S. et al. Lack of blinding of outcome assessors in animal model experiments implies risk of observer bias. J Clin Epidemiol 67, 973-983, doi: 10. 1016/j. jclinepi. 2014. 04. 008 (2014).
32. Rosen, R. F., Tomidokoro, Y., Ghiso, J. A., Walker, L. C. SDS-PAGE/immunoblot detection of Abeta multimers in human cortical tissue homogenates using antigen-epitope retrieval. J Vis Exp, doi: 10. 3791/1916 (2010).
33. Schaffer, S. et al. The effect of dichloroacetate on health-and lifespan in C. elegans. Biogerontology 12, 195-209, doi: 10. 1007/s10522-010-9310-7 (2011).
34. Avery, L. The genetics of feeding in Caenorhabditis elegans. Genetics 133, 897-917 (1993).
35. Tsujimoto, T., Nakase, Y., Sugano, T. Firefly luminescence for ATP assay. Wakayama Med Rep 14, 29-32 (1970).
36. Varela, A. T. et al. Indirubin-3?-oxime impairs mitochondrial oxidative phosphorylation and prevents mitochondrial permeability transition induction. Toxicol Appl Pharmacol 233, 179-185, doi: 10. 1016/j. taap. 2008. 08. 005 (2008).
37. Birch-Machin, M. A., Briggs, H. L., Saborido, A. A., Bindoff, L. A., Turnbull, D. M. An evaluation of the measurement of the activities of complexes I-IV in the respiratory chain of human skeletal muscle mitochondria. Biochem Med Metab Biol 51, 35-42 (1994